Am J Cardiol

1. AMBROSE JA, Kiel R, AlBayati A
   Time to Tweak the Definition of Type 2 Myocardial Infarction.
   Am J Cardiol. 2024 Mar 23:S0002-9149(24)00222.
   

   >> Share

   
   
2. CASSESE S, Kastrati A
   The Chronic Dilemma of Chronic Total Occlusion Revascularization.
   Am J Cardiol. 2024;216:95-97.
   

   >> Share

   
   
3. SAKOWITZ S, Bakhtiyar SS, Curry J, Mallick S, et al
   Off-Pump Coronary Artery Bypass Grafting Does Not Confer Superior Outcomes Among Frail Patients.
   Am J Cardiol. 2024 Mar 23:S0002-9149(24)00215.
   

   >> Share

   
   
4. COMANICI M, Bulut HI, Raja SG
   10-Year Mortality of Off-Pump Versus On-Pump Coronary Artery Bypass Grafting: An Updated Systematic Review, Meta-Analysis, and Meta-Regression.
   Am J Cardiol. 2024 Mar 22:S0002-9149(24)00218.
   

   >> Share

   
   
5. OKUYA Y, Saito Y, Kitahara H, Kobayashi Y, et al
   Relation of Vasoreactivity in the Left and Right Coronary Arteries During Acetylcholine Spasm Provocation Testing.
   Am J Cardiol. 2024 Mar 22:S0002-9149(24)00216.
   

   >> Share

   
   

   
   Am J Emerg Med

6. HERZOG D, Scavelli CN
   Obstructive myocardial infarction with normal automated ECG interpretation: A case report.
   Am J Emerg Med. 2024 Mar 7:S0735-6757(24)00114.
   

   >> Share

   
   
7. TEKIN G, Tekin YK
   Takotsubo or Kounis syndrome; Diagnosis is made retrospectively.
   Am J Emerg Med. 2024;78:219-220.
   

   >> Share

   
   

   
   Am J Med

8. HOWICK V JF, Saric P, Elwazir M, Newman DB, et al
   A Pragmatic Study of Cardiovascular Disease During Long-Term COVID-19.
   Am J Med. 2024 Mar 26:S0002-9343(24)00162-1. doi: 10.1016/j.amjmed.2024.
   

   >> Share

   
   

   
   Ann Intern Med

9. WEISS J, Raghu VK, Paruchuri K, Zinzuwadia A, et al
   Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study.
   Ann Intern Med. 2024 Mar 26. doi: 10.7326/M23-1898.
   

   >> Share

   
   

   
   Ann Thorac Surg

10. SABIK JF 3RD, Mehaffey JH, Badhwar V, Ruel M, et al
    Multiarterial vs Single-Arterial Coronary Surgery: 10-Year Follow-up of 1 Million Patients.
    Ann Thorac Surg. 2024;117:780-788.
    

    >> Share

    
    

    
    BMJ

11. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
    Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
    BMJ. 2024;384:q637.
    

    >> Share

    
    

    
    Can J Cardiol

12. AKIOYAMEN LE, Ko DT, Cram P, Landon BE, et al
    Approaches to comparing the impact of socioeconomic disadvantage on acute myocardial infarction care within and across countries: a Scoping review.
    Can J Cardiol. 2024 Mar 26:S0828-282X(24)00274.
    

    >> Share

    
    

    
    Circ J

13. SASAKI S, Kawamori H, Toba T, Takeshige R, et al
    Diagnostic Accuracy of Pre-Transcatheter Aortic Valve Replacement Nitroglycerin-Free Fractional Flow Reserve-Computed Tomography-Based Physiological Assessment in Patients With Severe Aortic Stenosis for Predicting Post-Transcatheter Aortic Valve Repl
    Circ J. 2024;88:501-509.
    

    >> Share

    
    

    
    Circulation

14. SERRUYS PW, Revaiah PC
    The American Heart Association's Centennial and Percutaneous Coronary Intervention's Semi-Centennial.
    Circulation. 2024;149:973-978.
    

    >> Share

    
    
15. FENG J, Li Y, Li Y, Yin Q, et al
    Versican Promotes Cardiomyocyte Proliferation and Cardiac Repair.
    Circulation. 2024;149:1004-1015.
    

    >> Share

    
    
16. BERG-HANSEN K, Gopalasingam N, Christensen KH, Ladefoged B, et al
    Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Circulation. 2024 Mar 27. doi: 10.1161/CIRCULATIONAHA.123.067971.
    

    >> Share

    
    
17. 
    Correction to: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
    Circulation. 2024;149:e1023.
    

    >> Share

    
    
18. SHUEY MM, Wang Y, Xiang RR, Zou A, et al
    Aggregation and Contextualization of Murine Investigations Improves Discovery of Significant Human Atherosclerotic Cardiovascular Disease Associations.
    Circulation. 2024;149:1056-1058.
    

    >> Share

    
    
19. LUSEBRINK E, Binzenhofer L, Hering D, Villegas Sierra L, et al
    Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?
    Circulation. 2024;149:1033-1052.
    

    >> Share

    
    

    
    Clin Cardiol

20. BRZEZINSKI RY, Banai S, Katz Shalhav M, Stark M, et al
    The CRP troponin test (CTT) stratifies mortality risk in patients with non-ST elevation myocardial infarction (NSTEMI).
    Clin Cardiol. 2024;47:e24256.
    

    >> Share

    
    

    
    Eur Heart J

21. HENRY CM, Oseran AS, Zheng Z, Dong H, et al
    Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in the United States.
    Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093.
    

    >> Share

    
    
22. TSUDA K, Nagamatsu W, Morii I
    A collateral channel from the bronchial artery in chronic total occlusion of proximal right coronary artery.
    Eur Heart J. 2024;45:1087.
    

    >> Share

    
    
23. CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al
    Human papillomavirus infection and cardiovascular mortality: a cohort study.
    Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093.
    

    >> Share

    
    
24. WYLD M, Webster AC
    Myocardial infarction and stroke in patients with kidney failure: can we do better?
    Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

25. SCARSINI R, Portolan L, Della Mora F, Fabroni M, et al
    Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation.
    Heart. 2023 Dec 1:heartjnl-2023-323461. doi: 10.1136/heartjnl-2023-323461.
    

    >> Share

    
    
26. PEVERELLI M, Maughan RT, Gopalan D, Dweck MR, et al
    Use of coronarycomputed tomography for cardiovascular risk assessment in immune-mediated inflammatory diseases.
    Heart. 2024;110:545-551.
    

    >> Share

    
    

    
    Int J Cardiol

27. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
    Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
    Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
    

    >> Share

    
    

    
    J Am Coll Cardiol

28. SZAREK M, Bhatt DL, Miller M, Brinton EA, et al
    Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl.
    J Am Coll Cardiol. 2024 Mar 15:S0735-1097(24)00384.
    

    >> Share

    
    
29. BLAHA MJ, Bhatia HS
    Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy.
    J Am Coll Cardiol. 2024 Mar 9:S0735-1097(24)00944.
    

    >> Share

    
    
30. LI Z, Wereski R, Anand A, Lowry MT, et al
    Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule-out Myocardial Infarction at Presentation.
    J Am Coll Cardiol. 2024 Mar 13:S0735-1097(24)00912.
    

    >> Share

    
    
31. MAHLER SA, Ashburn NP, Supples MW, Hashemian T, et al
    Validation of the ACC Expert Consensus Decision Pathway for Patients With Chest Pain.
    J Am Coll Cardiol. 2024;83:1181-1190.
    

    >> Share

    
    
32. KONTOS MC, de Lemos JA
    Chest Pain in the Emergency Department: Chasing Perfection.
    J Am Coll Cardiol. 2024;83:1191-1193.
    

    >> Share

    
    
33. SCHNEIDER PA, Olin JW
    Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
    J Am Coll Cardiol. 2024;83:1222-1224.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

34. GAO L, Wang Q, Li MY, Zhang MM, et al
    A mechanism for the treatment of cardiovascular and renal disease.
    J Cardiovasc Pharmacol. 2024 Mar 14. doi: 10.1097/FJC.0000000000001562.
    

    >> Share

    
    
35. SIMEONE B, Rocco E, Biondi-Zoccai G, Versaci F, et al
    N-Acetylcysteine: The Next Best Thing for Cardiovascular Interventions and Surgery?
    J Cardiovasc Pharmacol. 2024 Mar 14. doi: 10.1097/FJC.0000000000001558.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

36. QIU Z, Lee DH, Lu Q, Li R, et al
    Associations of Regional Body Fat with Risk of Cardiovascular Disease and Mortality among Individuals with Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Mar 26:dgae192. doi: 10.1210.
    

    >> Share

    
    

    
    JAMA

37. YEH RW, Shlofmitz R, Moses J, Bachinsky W, et al
    Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.
    JAMA. 2024;331:1015-1024.
    

    >> Share

    
    
38. KUNDU A, Moliterno DJ
    Drug-Coated Balloons for In-Stent Restenosis-Finally Leaving Nothing Behind for US Patients.
    JAMA. 2024;331:1011-1012.
    

    >> Share

    
    

    
    PLoS One

39. KIM A, Kang D, Choi SC, Cho J, et al
    Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score.
    PLoS One. 2024;19:e0301126.
    

    >> Share

    
    
40. KANG J, Marin-Cuartas M, Flo Forner A, Menon PR, et al
    Mortality in patients with normal left ventricular function requiring emergency VA-ECMO for postcardiotomy cardiogenic shock due to coronary malperfusion.
    PLoS One. 2024;19:e0300568.
    

    >> Share

    
    

    
    Prog Cardiovasc Dis

41. LIPPI G, Sanchis-Gomar F, Lavie CJ
    Excess mortality for acute myocardial infarction in the United States during the first two years of the COVID-19 pandemic.
    Prog Cardiovasc Dis. 2024 Mar 20:S0033-0620(24)00051.
    

    >> Share

    
    
42. TUTOR A, O'Keefe EL, Lavie CJ, Elagizi A, et al
    Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00054.
    

    >> Share

    
    
43. LAKSHMANAN S, Wei J, Cook-Wiens G, Pepine CJ, et al
    Comparison of risk profiles of participants in the Women's IschemiA TRial to reduce events in non-ObstRuctive CAD (WARRIOR) trial, using coronary computed tomography angiography vs invasive coronary angiography.
    Prog Cardiovasc Dis. 2024 Mar 26:S0033-0620(24)00053.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share